Duality Biotherapeutics Inc Ownership
HK$210.60
6.63%
Hong Kong, Sep 21, 03:46 pm HKT.
Closed.
Why the stock moved Beta
ISIN
KYG2929M1087
Symbol
9606
Industry
Duality Biotherapeutics Inc Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Lilly Asia Ventures
|
11.653m | 13.03% | — | Jan 31 2026 |
| 2 |
Zhu (Zhongyuan Ph.D.)
|
6.539m | 7.31% | +38.600k | Dec 17 2025 |
| 3 |
Shanghai Yingjia Enterprise Management Partnership (LP)
|
6.388m | 7.14% | +6.388m | Apr 15 2025 |
| 4 |
King Star Med LP
|
4.500m | 5.03% | -780.000k | Mar 12 2026 |
| 5 |
WuXi Biologics (Cayman) Inc.
|
4.170m | 4.66% | +4.170m | Apr 14 2025 |
|
1
Lilly Asia Ventures
|
13.03%
11.653m
|
|
2
Zhu (Zhongyuan Ph.D.)
|
7.31%
6.539m
|
|
3
Shanghai Yingjia Enterprise Management Partnership (LP)
|
7.14%
6.388m
|
|
4
King Star Med LP
|
5.03%
4.500m
|
|
5
WuXi Biologics (Cayman) Inc.
|
4.66%
4.170m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 37.18% of Duality Biotherapeutics Inc, with Lilly Asia Ventures the biggest at 13.03%, followed by Zhu (Zhongyuan Ph.D.) (7.31%) and Shanghai Yingjia Enterprise Management Partnership (LP) (7.14%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
